Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer
Current Issues in Molecular Biology · 11.03.2026 · 48 (3) · 300
DOI: 10.3390/cimb48030300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 11.03.2026. Verfasst von Li Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Anhui Medical University, Hefei 230032, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key projects of Natural Science Research Projects in Colleges and Universities of Anhui Province, Research Fund of Anhui Institute of Translational Medicine, Graduate Student Innovation and Entrepreneurship Practice Provincial Project.
Abstract (Originalsprache)
Gastric cancer (GC) remains a major global health burden, and increasing evidence suggests that ferroptosis plays an important role in regulating tumor cell survival. Phosphatidylserine decarboxylase (PISD) is a key mitochondrial enzyme responsible for phosphatidylethanolamine (PE) synthesis; however, its molecular function in GC remains poorly understood. In this study, we suggest that downregulation of PISD is associated with enhanced ferroptosis in GC cells by disrupting mitochondrial PE homeostasis and impairing mitochondrial function. Mechanistically, PISD depletion reduces PE levels, is accompanied by a reduction in signal transducer and activator of transcription 3 (STAT3) phosphorylation, and decreases GPX4 expression, leading to enhanced lipid peroxidation, iron accumulation, and redox imbalance. Pharmacological inhibition of ferroptosis using Ferrostatin-1 (Fer-1), activation of STAT3 by ML115, or supplementation with lysophosphatidylethanolamine (LPE) partially rescues PISD knockdown-induced ferroptosis. In vivo, PISD downregulation is significantly accompanied by a reduction in tumor growth in GC xenograft models. Collectively, our findings reveal a previously unrecognized role of PISD in linking mitochondrial phospholipid metabolism to STAT3/GPX4-dependent ferroptosis, providing mechanistic insights into the regulation of ferroptosis in gastric cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Basic Medicine, Anhui Medical University, Hefei 230032, China.
- Inspection Department, Yuetang District Center for Disease Control and Prevention, Xiangtan 411100, China.
- School of Pharmacy, Anhui Medical University, Hefei 230032, China.
- School of Life Sciences, Westlake University, Hangzhou 310000, China.
Förderung
- the Key projects of Natural Science Research Projects in Colleges and Universities of Anhui Province
- Research Fund of Anhui Institute of Translational Medicine
- Graduate Student Innovation and Entrepreneurship Practice Provincial Project
- College Students' Innovation and Entrepreneurship Training Program
- Key Projects of Natural Science Research Projects in Colleges and Universities of Anhui Province
- College Students’ Innovation and Entrepreneurship Training Program
Zitieren
APA
Wang, L., Wang, Y., Shao, M., Wang, T., Zheng, W., Cao, J., Luo, R., Tu, Y., Xia, Y., Wei, Y., Liu, N., Lu, W., & Xu, Y. (2026). Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer. Current Issues in Molecular Biology, 48(3), 300. https://doi.org/10.3390/cimb48030300
Vancouver
Wang L, Wang Y, Shao M, Wang T, Zheng W, Cao J, et al. Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer. Current Issues in Molecular Biology. 2026;48(3):300. doi:10.3390/cimb48030300
BibTeX
@article{Wang2026,
author = {Wang, Li and Wang, Yaoxing and Shao, Mingkai and Wang, Tao and Zheng, Wanbao and Cao, Jun and Luo, Renwen and Tu, Youyan and Xia, Yiting and Wei, Yiming and Liu, Ning and Lu, Wenjie and Xu, Youzhi},
title = {Phosphatidylserine Decarboxylase Promotes Ferroptosis Through STAT3/GPX4 Signaling in Gastric Cancer},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {3},
pages = {300},
doi = {10.3390/cimb48030300}
}
EUVIMED